Bing-Huei  Chen

Bing-Huei Chen

Food Science and Technology

Fu Jen University, Taipei, Taiwan

Professor Bing-Huei Chen received his PhD in Food Science and Technology from Texas A&M University, USA, in 1988. His post-graduate career includes posts at Fu Jen University, Taipei, Taiwan as Associate Professor from 1988–1994 then as Professor from 1994–2004. He went on to become Distinguished Chair Professor from 2003–present we well as Chair of Department of Nutrition and Food Science from 1994-2000, Director of Graduate Institute of Medicine from 2006–2009 and Dean of College of Human Ecology from 2012–2015. He specializes in Lipid Chemistry, Pigment Chemistry, Instrumental Analysis, Food Toxicology, Functional Food and Botanical Drug Development and Biological Activity Determination as well as Nanotechnology. He has published 194 research articles and has authored 11 chapters with renowned international publishers and journals. He also serves as Editor-in-Chief of the journal “Recent Patents on Food, Nutrition and Agriculture” and Associate Editor of 2 journals “Journal of Food & Drug Analysis” and “Asian Science Bulletin”. In addition, he serves on the editorial board of 135 journals. Currently he is the President of Professors Association, Taiwan and was the Past President of AOAC Taiwan section from 2016-2018. Alongside this Professor Chen has received numerous awards, include the prestigious National Invention Gold Medal Award by Ministry of Economics, Taiwan in 2018 and was honored with Outstanding Research Scientist by Ministry of Science and Technology, Taiwan. He was also honored with International Outstanding Inventor of Biotechnology by Taiwan Inventor Association/International Innovation and Invention Alliance Association in 2019 and Distinguished Professor by Chinese Academy of Agricultural Sciences, China in 2015. More recently, the International Association of Advanced Materials (IAAM), a European organization has honored him with IAAM Scientist Award 2020 for his contribution to the advancement of science and technology. At the same year he was also honored with Vebleo Fellow. Most importantly, Professor Chen has developed a nano-product “Lycopene Chylomicron”, which has completed a phase III clinical trial in both Taiwan and USA in 2017 and demonstrated to be effective in the treatment of patients with prostatauxe syndrome. Expectedly, this product will become the first botanic drug in the world for treatment of patients with prostatauxe syndrome without side effect.